{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T22:49:20Z","timestamp":1792363760306,"version":"4.4.0"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,5,5]]},"DOI":"10.7759\/cureus.83541","type":"journal-article","created":{"date-parts":[[2025,5,6]],"date-time":"2025-05-06T04:24:35Z","timestamp":1746505475000},"source":"Crossref","is-referenced-by-count":2,"title":["Lenvatinib-Associated Vaginal Necrosis and Rectovaginal Fistula After Brachytherapy"],"prefix":"10.7759","author":[{"given":"Keiichiro","family":"Baba","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taisuke","family":"Sumiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Saito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Motohiro","family":"Murakami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideyuki","family":"Sakurai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2108330","article-title":"Lenvatinib plus pembrolizumab for advanced endometrial cancer","volume":"386","author":"Makker V","year":"2022","unstructured":"Makker V, Colombo N, Casado Herr\u00e1ez A, et al.. Lenvatinib plus pembrolizumab for advanced endometrial cancer. N Engl J Med. 2022, 386:437-48. 10.1056\/NEJMoa2108330","journal-title":"N Engl J Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.17998\/jlc.2021.09.20","article-title":"A case report of a patient presented with skin ulcer after treatment of lenvatinib","volume":"21","author":"Cha S","year":"2021","unstructured":"Cha S, Kim DW, Choe JW, et al.. A case report of a patient presented with skin ulcer after treatment of lenvatinib. J Liver Cancer. 2021, 21:194-8. 10.17998\/jlc.2021.09.20","journal-title":"J Liver Cancer"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1159\/000525569","article-title":"Bowel perforation in a patient with hepatocellular carcinoma during lenvatinib treatment","volume":"16","author":"Mizokami K","year":"2022","unstructured":"Mizokami K, Watanabe A, Yamaguchi E, Saito A. Bowel perforation in a patient with hepatocellular carcinoma during lenvatinib treatment. Case Rep Gastroenterol. 2022, 16:502-6. 10.1159\/000525569","journal-title":"Case Rep Gastroenterol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1002\/jcph.2312","article-title":"Disproportionality analysis of lenvatinib-caused gastrointestinal perforation in cancer patients: a pharmacovigilance analysis based on the US Food and Drug Administration Adverse Event Reporting System","volume":"63","author":"Zhou J","year":"2023","unstructured":"Zhou J, Wei Z, Zheng Y, et al.. Disproportionality analysis of lenvatinib-caused gastrointestinal perforation in cancer patients: a pharmacovigilance analysis based on the US Food and Drug Administration Adverse Event Reporting System. J Clin Pharmacol. 2023, 63:1133-40. 10.1002\/jcph.2312","journal-title":"J Clin Pharmacol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2020.11.025","article-title":"Vaginal necrosis: a rare late toxicity after radiation therapy","volume":"160","author":"Jia AY","year":"2021","unstructured":"Jia AY, Viswanathan AN. Vaginal necrosis: a rare late toxicity after radiation therapy. Gynecol Oncol. 2021, 160:602-9. 10.1016\/j.ygyno.2020.11.025","journal-title":"Gynecol Oncol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2013.05.012","article-title":"Increased bowel toxicity in patients treated with a vascular endothelial growth factor inhibitor (VEGFI) after stereotactic body radiation therapy (SBRT)","volume":"87","author":"Barney BM","year":"2013","unstructured":"Barney BM, Markovic SN, Laack NN, et al.. Increased bowel toxicity in patients treated with a vascular endothelial growth factor inhibitor (VEGFI) after stereotactic body radiation therapy (SBRT). Int J Radiat Oncol Biol Phys. 2013, 87:73-80. 10.1016\/j.ijrobp.2013.05.012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctro.2018.01.001","article-title":"The EMBRACE II study: the outcome and prospect of two decades of evolution within the GEC-ESTRO GYN working group and the EMBRACE studies","volume":"9","author":"P\u00f6tter R","year":"2018","unstructured":"P\u00f6tter R, Tanderup K, Kirisits C, et al.. The EMBRACE II study: the outcome and prospect of two decades of evolution within the GEC-ESTRO GYN working group and the EMBRACE studies. Clin Transl Radiat Oncol. 2018, 9:48-60. 10.1016\/j.ctro.2018.01.001","journal-title":"Clin Transl Radiat Oncol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1111\/IGC.0b013e3181c4a63f","article-title":"Total vaginal necrosis: a representative example of underreporting severe late toxic reaction after concomitant chemoradiation for cervical cancer","volume":"20","author":"G\u00fcth U","year":"2010","unstructured":"G\u00fcth U, Ella WA, Olaitan A, Hadwin RJ, Arora R, McCormack M. Total vaginal necrosis: a representative example of underreporting severe late toxic reaction after concomitant chemoradiation for cervical cancer. Int J Gynecol Cancer. 2010, 20:54-60. 10.1111\/IGC.0b013e3181c4a63f","journal-title":"Int J Gynecol Cancer"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2005.12.008","article-title":"Predictors of severe gastrointestinal toxicity after external beam radiotherapy and interstitial brachytherapy for advanced or recurrent gynecologic malignancies","volume":"65","author":"Kasibhatla M","year":"2006","unstructured":"Kasibhatla M, Clough RW, Montana GS, Oleson JR, Light K, Steffey BA, Jones EL. Predictors of severe gastrointestinal toxicity after external beam radiotherapy and interstitial brachytherapy for advanced or recurrent gynecologic malignancies. Int J Radiat Oncol Biol Phys. 2006, 65:398-403. 10.1016\/j.ijrobp.2005.12.008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2016.06.006","article-title":"Dose-volume effect relationships for late rectal morbidity in patients treated with chemoradiation and MRI-guided adaptive brachytherapy for locally advanced cervical cancer: results from the prospective multicenter EMBRACE study","volume":"120","author":"Mazeron R","year":"2016","unstructured":"Mazeron R, Fokdal LU, Kirchheiner K, et al.. Dose-volume effect relationships for late rectal morbidity in patients treated with chemoradiation and MRI-guided adaptive brachytherapy for locally advanced cervical cancer: results from the prospective multicenter EMBRACE study. Radiother Oncol. 2016, 120:412-9. 10.1016\/j.radonc.2016.06.006","journal-title":"Radiother Oncol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1007\/s12328-023-01802-0","article-title":"Severe skin ulcer caused by taking lenvatinib after proton beam therapy","volume":"16","author":"Iwasa T","year":"2023","unstructured":"Iwasa T, Adachi S, Ogiso H, et al.. Severe skin ulcer caused by taking lenvatinib after proton beam therapy. Clin J Gastroenterol. 2023, 16:588-92. 10.1007\/s12328-023-01802-0","journal-title":"Clin J Gastroenterol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2023.14139","article-title":"Rectal ulcer associated with lenvatinib 15\u00a0years after definitive radiotherapy for prostate cancer: a case report","volume":"27","author":"Kawata Y","year":"2024","unstructured":"Kawata Y, Watanabe K, Tokiya R, Miyaji Y, Shiotani A, Katsui K. Rectal ulcer associated with lenvatinib 15\u00a0years after definitive radiotherapy for prostate cancer: a case report. Oncol Lett. 2024, 27:6. 10.3892\/ol.2023.14139","journal-title":"Oncol Lett"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2302312","article-title":"Pembrolizumab plus chemotherapy in advanced endometrial cancer","volume":"388","author":"Eskander RN","year":"2023","unstructured":"Eskander RN, Sill MW, Beffa L, et al.. Pembrolizumab plus chemotherapy in advanced endometrial cancer. N Engl J Med. 2023, 388:2159-70. 10.1056\/NEJMoa2302312","journal-title":"N Engl J Med"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2020.09.016","article-title":"Current status of clinical trials for cervical and uterine cancer using immunotherapy combined with radiation","volume":"109","author":"Dyer BA","year":"2021","unstructured":"Dyer BA, Feng CH, Eskander R, Sharabi AB, Mell LK, McHale M, Mayadev JS. Current status of clinical trials for cervical and uterine cancer using immunotherapy combined with radiation. Int J Radiat Oncol Biol Phys. 2021, 109:396-412. 10.1016\/j.ijrobp.2020.09.016","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.3747\/co.v18i5.767","article-title":"Hyperbaric oxygen therapy for late radiation tissue injury in gynecologic malignancies","volume":"18","author":"Craighead P","year":"2011","unstructured":"Craighead P, Shea-Budgell MA, Nation J, et al.. Hyperbaric oxygen therapy for late radiation tissue injury in gynecologic malignancies. Curr Oncol. 2011, 18:220-7. 10.3747\/co.v18i5.767","journal-title":"Curr Oncol"},{"key":"ref16","article-title":"Wound debridement","author":"Manna B","year":"2025","unstructured":"Manna B, Nahirniak P, Morrison CA. Wound debridement. StatPearls [Internet]. StatPearls Publishing, Treasure Island (FL); 2025."},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1272\/jnms.JNMS.2025_92-504","article-title":"Early laparoscopic colostomy in advanced cancer patients with rectovaginal fistula: results of seven patients","volume":"Online ahead of print","author":"Akita S","year":"2024","unstructured":"Akita S, Ishimaru K, Sato M, et al.. Early laparoscopic colostomy in advanced cancer patients with rectovaginal fistula: results of seven patients. J Nippon Med Sch. 2024, Online ahead of print:10.1272\/jnms.JNMS.2025_92-504","journal-title":"J Nippon Med Sch"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/355349-lenvatinib-associated-vaginal-necrosis-and-rectovaginal-fistula-after-brachytherapy","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,6]],"date-time":"2025-05-06T04:24:36Z","timestamp":1746505476000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/355349-lenvatinib-associated-vaginal-necrosis-and-rectovaginal-fistula-after-brachytherapy"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,5]]},"references-count":17,"URL":"https:\/\/doi.org\/10.7759\/cureus.83541","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5,5]]}}}